Paroxetine Hydrochloride Tablets USP recall — FDA D-0120-2024
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Complete FDA and NHTSA recall records dated in December 2023.
These records include useful source details for the selected month.
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
BMW of North America, LLC (BMW) is recalling certain 2023 Toyota GR Supra, 3 Series Sedan (330i xDrive, M340i xDrive, M3), 5 Series Sedan (530i, 530i xDrive, M5), 4 Series Gran Coupe (430i,…
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.